Aspire Biopharma Holdings Inc (ASBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -19,773 | -17,923 | -15,941 | -12,538 | -544 |
| Depreciation Amortization | 2,021 | N/A | N/A | N/A | N/A |
| Other Working Capital | -348 | -667 | -326 | 1,034 | -201 |
| Other Operating Activity | 14,105 | 15,698 | 14,516 | 9,449 | 0 |
| Operating Cash Flow | $-3,996 | $-2,892 | $-1,752 | $-2,055 | $-745 |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | 0 | 0 | 0 | 13,781 | 0 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $13,781 | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 493 |
| Debt Issued | 9,817 | 3,050 | 3,050 | 1,711 | N/A |
| Debt Repayment | -3,033 | N/A | N/A | N/A | N/A |
| Common Stock Issued | N/A | N/A | N/A | N/A | 258 |
| Common Stock Repurchased | N/A | N/A | N/A | -13,781 | N/A |
| Other Financing Activity | -844 | 44 | 44 | 343 | 0 |
| Financing Cash Flow | $5,940 | $3,094 | $3,094 | $-11,727 | $750 |
| Beginning Cash Position | 4 | 4 | 4 | N/A | 11 |
| End Cash Position | 1,948 | 206 | 1,347 | N/A | 17 |
| Net Cash Flow | $1,945 | $203 | $1,343 | $0 | $5 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,996 | -2,892 | -1,752 | -2,055 | -745 |
| Free Cash Flow | -3,996 | -2,892 | -1,752 | -2,055 | -745 |